To characterize the neuroendocrine patterns of abnormal GnRH secretion in hypothalamic amenorrhea (HA), 49 women with primary and secondary HA underwent frequent sampling of LH in a total of 72 baseline studies over 12-24 h. A subset of women participated in more than one study to address 1) the variability of LH pulse patterns over time; and 2) the impact of modulating opioid, dopaminergic, and adrenergic tone on LH secretory patterns.The frequency and amplitude of LH secretion was compared with that seen in the early follicular phase (EFP) of normally cycling women. The spectrum of abnormalities of LH pulses was 8% apulsatile, 27% low frequency/low amplitude, 8% low amplitude/normal frequency, 43% low frequency/normal amplitude, 14% normal frequency/normal amplitude. Of patients studied overnight, 45% demonstrated a pubertal pattern of augmented LH secretion during sleep. Of patients studied repeatedly, 75% demonstrated at least 2 different patterns of LH secretion, and 33% reverted at least once to a normal pattern of secretion. An increase in LH pulse frequency was seen in 12 of 15 subjects in response to naloxone (opioid receptor antagonist). Clonidine (alpha-2 adrenergic agonist) was associated with a decrease in mean LH in 3 of 3 subjects. An increase in LH pulse frequency was seen in 4 of 8 subjects in response to metoclopramide (dopamine receptor antagonist), but the response was not statistically significant. Baseline abnormalities in LH secretion did not appear to influence response to neurotransmitter modulation. Conclusions: 1) HA represents a spectrum of disordered GnRH secretion that can vary over time; 2) LH pulse patterns at baseline do not appear to influence the ability to respond to neurotransmitter modulation; 3) Opioid and adrenergic tone appear to influence the hypothalamic GnRH pulse generator in some individuals with HA. (J Clin Endocrinol Metab 84: 1905-1911, 1999 H YPOTHALAMIC amenorrhea (HA) is a clinical syndrome characterized by amenorrhea, hypoestrogenism, and normal or low serum gonadotropins. HA accounts for up to 48% of secondary amenorrhea (1) and is of particular clinical importance as the hypoestrogenism associated with HA has been correlated with decreased bone density (2, 3). Previous work, including our own, suggests that this disorder represents a spectrum of abnormal patterns of endogenous hypothalamic GnRH release (4, 5). HA has been associated with increased exercise, decreased weight, and stress in some patients, while in many, no inciting features can be identified. Importantly, even in those for whom causative factors have been suggested, the precise mechanism of disruption of GnRH secretion has not been elucidated.Because direct measurement of hypothalamic GnRH in humans is not possible, studies have used LH as an index of hypothalamic GnRH secretion. Patients with congenital GnRH deficiency [idiopathic hypogonadotropic hypogonadism (IHH) or Kallmann's syndrome when associated with anosmia] show a complete absence of pulsatile LH secretion, reflecting a co...